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muscle cells with cunditloned media for 24 hours; osteopontin mRNA was not 
detected in VSMC at baseline. These data suggest hat macrophoge-smooth 
muscle cell interactions are responsible for the coil proliferation and matrix 
production associated with coronary artery disease. 
~ Enzyme Independent Formation of Nitric Oxide Is 
Triggered During Myocardial Ischemla and Results 
in Post Is©heroic Injury 
Jay L. Zweier, Penghai Wang, Nexandre Sarnouilov, 
Pedannan Kuppusamy. The Johns Hopkins Medical Institutions, Baltimore, 
Maryl~'~d 21224 
We have recenfly shown that NO" generation is greatly increased in ischemic 
tissues and results in cellular injury. While it has been generally assumed that 
the formation of NO" in biological tissues is solely due to direct synthesis by 
specific nitric oxide synthase enzymes (NOS), we observe that in ischemic 
tissues such as the heart, large quantities ot NO- can be formed by a mech- 
anism which is not enzyme dependent. Electron paramagneflc resonance, 
EPR, spectroscopy was applied to directly measure the mechanisms of NO" 
generation in the iechemic heart. NO" bound to either intrinsic heine proteins 
or to the spin trap Fe-MGD gives dse to charastedstic triplet signals which 
enable definitive measurement of NO" formed within the head. While only 
trace NO" triplet signals were seen pdor to ischemia, dudng ischemia these 
signals greatly increased indicating that marked NO" generatien occurred. 
White with short ischemic durations of 30 min or less, inhibition of NOS 
decreased NO" formation, inhibition was incomplete and with increasing du- 
rations of iechemia less that 50°/= inhibition was seen. When hearts were 
labeled with lSN nitrite and then subjected Io ischemia prominent doublet 
signals were observed arising from the lSN coupling to the unpaired electron, 
demonstrating that during ischemia nitdte was directly reduced giving rise to 
large amounts of NO*. With long penods of ischemia progressing to necrosis 
this mechanism of NO" formation predominated and it was further observed 
that this NO* generation resulted in myocaroiial injury with a less oi contra~le 
function. The existence of this enzyme independent mechanism of NO" for- 
malign has important implications in our understanding of the pathogenesis 
and treatment of tissue injury. 
~ Selective Activation of the Endothelin-B Receptor: 
Regional Vascular Act ions in Vivo 
Todd E. Rasmussen, Michihisa Jougasaki. Thanom Supapom, John 
C. Bumett Jr.. Cardiorenal Research Laboratory. Mayo Clinic. Rochester, 
Mn 
Eodothelin-1 is a potent vasoconstdctor peptide which exerts its a~ons 
through two distinct receptor subtypes, the Endothelin-A (ET-A) and Endothefin- 
B (ET-B) receptors. Studies demonstrate that the ETA receptor is expressed 
in vascular smooth muscle and activation results in vasoconstriction. The 
ET-B receptor is present on endothelial colts as well as smooth muscle ceils. 
Controversy exists as to the action of the ET-B receptor upon regional vas- 
cular tone. The current study was designed to assess the in vivo activity of 
selective ET-B receptor activation with sarafotoxin on regional circulations at 
paracdne (5 ng/kg/min), pathophysiologic (25 ng/kg/min) and pharmacologic 
(50 og/kg/min) doses in the normal dog (N = 5). 
Baset(ne 5 n 9 25 ng S0 ng 
SVR, RU S0±3 304-3 3S:J:3 56 :t:6* 
PVR, RU 3.6 ± 0.43 3.9 ~:0.5' 4.7 :t: 0.6 5.74-0.8" 
CVR, RU 2.8 :k 1.2 1.6 :i: 0.4 1.84- 0,3 2.1 4- 0.7 
RVR, RU 0.4 4- 0.06 0A :t: 0.03 0.4 =t: 0.02 0.5 :l: 0.06" 
• p < 0.05 vs Baseline 
In addition, co-administration f a sefective ETA receptor antagonist, FR- 
139317 (10 ~g/kg/min), was performed (N = 4) to exclude co-activation 
of the ET-A receptor by sarafotoxin. Co-administration failed to alter the 
vascular response to sarafotoxin. These results demonstrate that selective 
activation of the ET-B receptor at paracdne and pathophysiologic doses 
results in no vassconstdction with a tendency to decrease coronary vascular 
resistance. However, pharmacologic activation resulted in significant renal, 
pulmonary and systemic vasoconstriction without corona~ vasoconstriction. 
These results demonstrate unequivocally an important invivo vasoconstrictor 
role for the ET-B receptor in the systemic, pulmonary and renal circulations. 
~ Inhib|tion of Endothelial-Derived Fsofor Relaxing 
Enhances the Coronary Vasoconstriction to 
Endofhelin-B Activation 
Charles R. Carman, John C. Bumett Jr., Amir Lerman. Mayo Clinic, 
Rochester, MN 
ET, a corona~ vasoconstrictor, mediates its activity through two specific ETA 
and ET-B receptors. Studies demonstrated that ET-B receptorS are located 
on both the endothelium and vascular smooth muscle celts and may mediate 
vasodJ/atation via the re/ease of endothelium-dedved relaxing factor (EDRF] 
offsets direct vasoconstrictive activity. The current stUdy was design to test 
the hypothesis that the inhibition of EDRF may enhance the coronazy vase- 
constriction to specific ET-B receptor stimulation with sarafetoxin, aselective 
ET-B receptor agonist. Therefore, sarafutoxin (Group 1, n = 5), and Sarefo- 
toxin + NG-monomethyl-L-arginine (LNMMA, 50/~g/kg/min). (Group 2, n = 
5) were infused into the left circumflex coronary artery, in the anesthetized 
dog, No difference in hemodynamics and comnmy blood flow (CBF), core- 
nan/vascular esistance (CVR) and coronary artery diameter (CAD) were 
observed at baseline. CBF, CVR and CAD were determined at baseline and 
during inlusions and were calculated as % change (A) from baseline. 
Sara~otoxin Sarafotoxin + LNMMA ' " 
%'& CBF --7 4- 3 -28 4- 7* 
% ~ CVR 12:E8 674-24" 
% ,'t CAD -1.S 4- 0.7 02±0.2 
*p < 0.05 between Groups. 
This study demonstrates that the inh~on of EDRF enhances the coronary 
vaseconstdction to sarafotoxin which occurred predominantly at the level 
of the coronary microcircutation. This study suggests that ET-B mediated 
release of EDRF anoVor basal produ~on of EDRF offset the direct comnsxy 
vasoconstrictive action of the ET-B receptom in the coronary mic~ocirculation. 
~ Effeof of Nitric Oxide on the Pulmonary Vascular 
Pressure-Flow Relationship in a Canine Model of 
Thrombofytio Pulmonary Hypertension 
I=. H. Shiffman, R. M. Prewitt, U. Schick, J. Duces. Health Sciences CentTe, 
University of Manitoba, Winnipeg, Manitoba, Canada 
Nitric oxide (NO) has been shown to be effective in reducing pulmonary aden/ 
pressure in many forms of pulmonary hypertension. While the inlracallular 
mechanism of action is known, the pulmonary hemodynamic effects are 
not fully elucidated. This study examined the effects of inhaled NO on the 
pulmonary vascular pressure-flow (P-Q) relationship in a canine model of 
pulmonary embolism. According to P-Q theory, the slope of the P-Q plot 
defines the mctementa~ vascular resiefanco (unit pressure change per unit 
change in flow) and the extrapolated pressure intercept defines the affect~e 
vascular outflow pressure. Six dogs were embolized with autologous blood 
clot to create pulmonary hypertension complicated by a low cardiac output 
state. To define the P-Q plot, multiple mean pulmonary artery pressure (PAP) 
vs cardiac output (CO) coordinates were obtained pre and pest embolization, 
and before, during and alter treatment with nitric oxide (180-200 ppm). 
The PAP-CO coordinates were obtained by varying flow through systemic 
artedoveneus fistulas. Embolization increased PAP (14.8 :E 1.2 to 34.6 :E 
4.6; p < 0.001 )and decreased CO (3.45 ± 0.63 to 2.25:1: 0.43; p < 0.05). All 
PAP-CO relationships were well descnl)ed by a linear equation (mean rvalue 
0.921 :E 0.029). Both the slope and intercept of the PAP-CO plot increased 
with embelization, (1A1 ± 0.09 to 3.51 :k 1.22; p < 0.05 and 9.9 + 1.1 to 
28.0 ± 6.5; p < 0.005 respectively). NO significantly improved pulmonary 
hemodynamics. The intercept of the PAP-CO plot decreased from the ~nitial 
control of 28.0 mmHg to 22.5 mmHg (p < g.05), and Iollowing discontinuation 
of the NO, increased to 26.2 mmHg Co < 0.05). The slope was not affected. 
Furthermore, NO did not affect systemic bemedynarnics. In this model of 
pulmonaJ7 embolism, the increase in PAP is predominantly explained by 
an increase in the extrapolated pressure intercept (P0 and NO selectively 
improved pulmonary hemodynamics bydecreesing Pc. C_~ndusian: Based on 
previous work, it is most likely that the decrease in Pj represents a localized 
decrease in pulmonary vascular tone upstream from the capillary bed. 
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